MCQs on "Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes" Answers with Explanations and References

被引:0
|
作者
不详
机构
关键词
ESTROGEN-RECEPTOR; CANCER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:198 / 200
页数:3
相关论文
共 50 条
  • [41] Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes
    Arun, B
    Kilic, G
    Yen, C
    Foster, B
    Yardley, D
    Gaynor, R
    Ashfaq, R
    CANCER, 2003, 98 (12) : 2554 - 2559
  • [42] ER、PR、HER-2、P53和KI67在四种乳腺癌中表达
    夏琛
    吴义启
    湖北科技学院学报(医学版), 2017, 31 (04) : 280 - 282
  • [43] Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
    Reiki Nishimura
    Tomofumi Osako
    Yasuhiro Okumura
    Rumiko Tashima
    Yasuo Toyozumi
    Nobuyuki Arima
    World Journal of Surgical Oncology, 9
  • [44] Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Tashima, Rumiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
  • [45] Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer
    Shaaban, A.
    Badr, N.
    Zaakouk, M.
    Kearns, D.
    Kong, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S87 - S88
  • [46] Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision
    Georgescu, Rares
    Boros, Monica
    Moncea, Denisa
    Bauer, Orsolya
    Coros, Marius-Florin
    Oprea, Adela
    Moldovan, Cosmin
    Podoleanu, Cristian
    Stolnicu, Simona
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (08) : 533 - 538
  • [47] EXPRESSION OF ER/PR/HER2, BASAL MARKERS AND ADHESION MOLECULES IN PRIMARY BREAST CANCER AND IN LYMPH NODES METASTASES: A COMPARATIVE IMMUNOHISTOCHEMICAL ANALYSIS
    Adamczyk, Agnieszka
    Niemiec, Joanna
    Ambicka, Aleksandra
    Malecki, Krzysztof
    Wysocki, Wojciech H.
    Mitus, Jerzy
    Rys, Janusz
    POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 228 - 234
  • [48] Analysis of HER-2/neu expression and gene amplification in 1020 infiltrating breast carcinomas by IHC and CISH.: Correlation with tumor type, histological grade, lymph node status and ERα, PgR, p53 and ki-67 expression the hellenic multicenter study
    Valavanis, Christos
    Koutsoubi, Katerina
    Kouneli, Sofia
    Kapranos, Nikiforos
    Sotiropoulou, Maria
    Patakiouta, Frida
    Trihia, Helen
    Morphopoulos, George
    Papaspyrou, Irene
    Georgiadou, Elisabeth
    Toliou, Theofani
    Markaki, Sofia
    Bairaktari, Efi
    Apostolikas, Nikiforos
    Arapantoni-Dadioti, Petroula
    VIRCHOWS ARCHIV, 2007, 451 (02) : 147 - 147
  • [49] Hormone Receptor Status Rather Than HER2 Status Is Significantly Associated With Increased Ki-67 and p53 Expression in Triple-Negative Breast Carcinomas, and High Expression of Ki-67 but Not p53 Is Significantly Associated With Axillary Nodal Metastasis in Triple-Negative and High-Grade Non-Triple-Negative Breast Carcinomas
    Han, Jeong S.
    Cao, Dengfeng
    Molberg, Kyle H.
    Sarode, Venetia R.
    Rao, Roshni
    Sutton, Lisa M.
    Peng, Yan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (02) : 230 - 237
  • [50] Discordant immunohistochemical characteristics (ER, PR, HER2, Ki67, FOXA1) between primary breast cancer, residual tumor and axillar lymph node metastasis after neoadjuvant chemotherapy
    Semiglazov, V.
    Bashlyk, V.
    Kudaybergenova, A.
    Artemyeva, A.
    Chirsky, V.
    Semiglazova, T.
    Klimenko, V.
    Paltuev, R.
    Tseluyko, A.
    Semiglazov, V.
    BREAST, 2019, 44 : S27 - S28